Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • kylle345
    Member
    • Apr 2009
    • 10

    Maq mismatch

    Hi,

    I am currently using the match function in maq to align sequence reads to a reference genome. I want to increase the mismatch to 5 or 6 but I notice that the limit is at 3. Is there anyway around this?

    thanks
  • nilshomer
    Nils Homer
    • Nov 2008
    • 1283

    #2
    Originally posted by kylle345 View Post
    Hi,

    I am currently using the match function in maq to align sequence reads to a reference genome. I want to increase the mismatch to 5 or 6 but I notice that the limit is at 3. Is there anyway around this?

    thanks
    You will have to use a different aligner. Aligners like BFAST, BWA, bowtie, etc (bowtie is not for SOLiD) will allow you to up the sensitivity at the expense of speed.

    Comment

    • kylle345
      Member
      • Apr 2009
      • 10

      #3
      hi

      Hey thanks for the reply,

      I am currently using bowtie since it is one of the programs that is used by our institute. I am wondering if this is the correct line to use in order to get up to 5 mismatches. If not then how would I do this?

      bowtie -y --maxbts --best -n 5 -q

      Comment

      • nilshomer
        Nils Homer
        • Nov 2008
        • 1283

        #4
        Originally posted by kylle345 View Post
        Hey thanks for the reply,

        I am currently using bowtie since it is one of the programs that is used by our institute. I am wondering if this is the correct line to use in order to get up to 5 mismatches. If not then how would I do this?

        bowtie -y --maxbts --best -n 5 -q
        Looks like the "-n" option can only range from 0-3.
        Code:
          -n/--seedmms <int> max mismatches in seed (can be 0-3, default: -n 2)
        PM Ben Langmead or post a new thread asking how to do this with bowtie. Alternatively, you can ask your institution to use BFAST, which allows you to a priori tune for sensitivity including indels. Admittedly I am the author for the latter.

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM
        • SEQadmin2
          Cancer Drug Resistance: The Lingering Barrier to Rising Survival
          by SEQadmin2



          Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

          There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
          07-08-2026, 05:17 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 07-24-2026, 12:17 PM
        0 responses
        26 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-23-2026, 11:41 AM
        0 responses
        21 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-20-2026, 11:10 AM
        0 responses
        210 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-13-2026, 10:26 AM
        0 responses
        78 views
        0 reactions
        Last Post SEQadmin2  
        Working...